InvestSMART

Cellmid Limited (ASX: CDY) - Announcements

- Current share price for CDY : $0.056

ASX company news and announcements for Cellmid Limited (CDY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cellmid Limited (CDY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cellmid Limited (CDY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cellmid Limited (CDY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- AGM Presentation to Shareholders 19 Nov 2019 12:58PM $0.235 $0.056 fallen by 76.17%
- Change of Director's Interest Notice - Cross 12 Nov 2019 1:09PM $0.210 $0.056 fallen by 73.33%
- Change of Director's Interest Notice - King 12 Nov 2019 1:06PM $0.210 $0.056 fallen by 73.33%
- Change of Director's Interest Notice - Gordon 12 Nov 2019 1:05PM $0.210 $0.056 fallen by 73.33%
- Appendix 3B and Cleansing Notice 8 Nov 2019 3:33PM $0.215 $0.056 fallen by 73.95%
- Cellmid Signs Trading Agreement With API/Priceline 6 Nov 2019 9:42AM $0.225 $0.056 fallen by 75.11%
- Cellmid Share Purchase Plan Completed 6 Nov 2019 9:30AM $0.225 $0.056 fallen by 75.11%
- Cellmid Appoints CEO to Advangen USA to Expand Distribution 31 Oct 2019 9:26AM $0.210 $0.056 fallen by 73.33%
- Supplementary Information on AGM Resolutions 24 Oct 2019 9:46AM $0.230 $0.056 fallen by 75.65%
- Appendix 4C and Notes to Appendix 4C 23 Oct 2019 10:55AM $0.220 $0.056 fallen by 74.55%
- Notice of Annual General Meeting/Proxy Form 18 Oct 2019 2:07PM $0.195 $0.056 fallen by 71.28%
- Appendix 3B and Cleansing Notice 18 Oct 2019 1:37PM $0.195 $0.056 fallen by 71.28%
- SPP Offer Booklet 15 Oct 2019 8:56AM $0.225 $0.056 fallen by 75.11%
- Cleansing notice 15 Oct 2019 8:48AM $0.225 $0.056 fallen by 75.11%
- New TV Shopping Agreement for Evolis 14 Oct 2019 10:01AM $0.225 $0.056 fallen by 75.11%
- Cellmid Share Placement raises $1.5 million 14 Oct 2019 8:43AM $0.225 $0.056 fallen by 75.11%
- Trading Halt 10 Oct 2019 8:59AM $0.225 $0.056 fallen by 75.11%
- New Evolis Distribution & Supply Agreements - China & Europe 1 Oct 2019 10:29AM $0.235 $0.056 fallen by 76.17%
- Cellmid receives R&D tax credit 27 Sep 2019 9:57AM $0.240 $0.056 fallen by 76.67%
- Appendix 4G and Corporate Governance Statement 16 Sep 2019 10:23AM $0.240 $0.056 fallen by 76.67%
- Annual Report to shareholders 16 Sep 2019 10:13AM $0.240 $0.056 fallen by 76.67%
- FY19 Results Presentation 28 Aug 2019 1:55PM $0.230 $0.056 fallen by 75.65%
- FY2019 Financial Results 28 Aug 2019 1:46PM $0.230 $0.056 fallen by 75.65%
- Appendix 4E and FY19 Financial Report 28 Aug 2019 1:46PM $0.230 $0.056 fallen by 75.65%
- Patent for Improved Midkine Antibody Allowed in Europe 22 Aug 2019 11:20AM $0.215 $0.056 fallen by 73.95%

151 - 175 of 530 results

Page 7 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.